Pharmaceutical Compliance Program Elements
Pharmaceutical Compliance Program ElementsPharmaceutical Compliance ForumSeptember 15, 2009Bridgewater, NJJohn T. BentivoglioSkadden, ArpsMatthew D AmbrosioProstrakan, of Discussion Sentencing Guidelines HHS OIG Guidance DOJ Guidance on Compliance programs Advanced Pharma Compliance Issues DiscussionA Brief History of Corporate federal Sentencing Guidelines1996CaremarkDecision2001Enron Collapse &TAP Settlement2002PhRMACode&SOX2004Amended SentencingGuidelines1997OIGModel ComplianceGuidelines(Clinical Labs)2003OIGPharmaGuidelines&DOJ sThompsonMemoCompliance Time Line2005Corporate Sentencing Guidelines provide reduction in fines for effective Compliance programs . Seven Elements a cause of action against board members for failing to take minimal steps to achieve legal Compliance now known as a Caremark Claim .Guidelines for US Attorneys in charging on real v.
A Brief History of Corporate Compliance 1991 U.S. Federal Sentencing Guidelines 1996 Caremark Decision 2001 Enron Collapse & TAP Settlement 2002 PhRMA Code
Download Pharmaceutical Compliance Program Elements
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Compliance and Internal Audit: A Dangerous, Compliance and Internal Audit: A Dangerous Combination, CALIFORNIA, Compliance, State of California—Health and Human Services, State of California—Health and Human Services Agency, California State Board of Pharmacy and Medical, Of California, Cryptocurrency Compliance: An AML Perspective, State, University of California Audit and Communications, Information on the Questionable, Federal